Jacobs Levy Equity Management’s Aardvark Therapeutics AARD Stock Holding History
Bought
Maintained
Sold
Other funds holding AARD
Jacobs Levy Equity Management's AARD Position: Q3 2026 in Review
Jacobs Levy Equity Management opened a new position in Aardvark Therapeutics (AARD) in Q3 2026: 130,165 shares worth $686K. The stake represents ﹤0.01% of the portfolio and ranks #730 among its holdings.
76 funds tracked by Wall St. Rank hold AARD as of Q3 2026.
- Jacobs Levy Equity Management held 130,165 shares of Aardvark Therapeutics worth $686K as of Q3 2026.
- Aardvark Therapeutics was a new Jacobs Levy Equity Management position in Q3 2026.
- Aardvark Therapeutics made up ﹤0.01% of Jacobs Levy Equity Management's portfolio in Q3 2026, its #730 holding.
- 76 funds tracked by Wall St. Rank held Aardvark Therapeutics as of Q3 2026.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2026, filed 16 Nov 2026.